Pharmacologic treatment of hypertension in patients with chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Hypertension is a significant contributor to morbidity and mortality in patients with chronic kidney disease (CKD).
• CKD is characterized by a high prevalence of hypertension, with suboptimal control rates.
• Untreated or poorly controlled hypertension exacerbates renal dysfunction and increases overall mortality risk in CKD patients.

Purpose of the Study:

• To review pharmacologic treatment options for hypertension in patients with various forms of chronic kidney disease.
• To highlight the importance of individualized treatment selection based on CKD etiology and patient comorbidities.
• To emphasize the necessity of multi-drug regimens for achieving blood pressure goals in this population.

Main Methods:

• Review of existing literature on hypertension management in chronic kidney disease.
• Analysis of pharmacologic treatment strategies, considering drug classes, efficacy, and safety.
• Discussion of non-pharmacologic interventions as a foundational element of care.

Main Results:

• Non-pharmacologic strategies are primary but often insufficient for hypertension control in CKD.
• Most CKD patients require multi-drug antihypertensive therapy to reach target blood pressure goals.
• Pharmacologic therapy selection must be tailored to the specific cause of kidney disease and co-existing conditions.

Conclusions:

• Effective management of hypertension is critical for improving outcomes in chronic kidney disease.
• Individualized pharmacologic approaches, often combining multiple agents, are essential for optimal blood pressure control.
• Further research may refine therapeutic strategies for hypertension in diverse CKD populations.